Accessibility Menu
Thc Therapeutics logo

Thc Therapeutics

(OTC) THCT

Current Price$0.00
Market Cap$20.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-100%
1 Year+150%
1 Month-83%

Thc Therapeutics Financials at a Glance

Market Cap

$20.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$562.78K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

21.71 (High)

Price

$0.00

Volume

30

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Nov 11, 2025

THCT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Therapeutics

Industry

Healthcare Equipment and Supplies

Employees

1

CEO

Scott A. Cox

Website

thct.io

Headquarters

Las Vegas, NV 89135, US

THCT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

12.06%

Return on Capital

N/A

Return on Assets

-2979.49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

40.27M

Volume

30

Avg. Volume

637.677

Financials (TTM)

Gross Profit

-$1.40K

Operating Income

-$574.72K

EBITDA

-$483.83K

Operating Cash Flow

-$182.51K

Capital Expenditure

$0.00

Free Cash Flow

-$182.51K

Cash & ST Invst.

$849.00

Total Debt

$731.79K

Thc Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$344.00

-1.2%

Gross Margin

0.00%

N/A

Market Cap

$20.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$20.10K

N/A

Employees

1

N/A

Net Income

$104.62K

+10.9%

EBITDA

$123.30K

+8.2%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$849.00

+5560.0%

Total Debt

$731.79K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$731.79K

+0.0%

Return on Assets

-29.79%

N/A

Return on Invested Capital

15.39%

N/A

Free Cash Flow

-$137.06K

-6192.9%

Operating Cash Flow

-$137.06K

-6193.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REMIRemedent, Inc.
$0.00+0.00%
NMXSNet Medical Xpress Solutions, Inc.
$0.00+0.00%
QMDTQuick-Med Technologies, Inc.
$0.00+0.00%
EMGEEmergent Health Corp
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$11.70+0.00%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.63-0.03%
INTCIntel
$107.76+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$75.02+0.03%

Questions About THCT

What is the current price of Thc Therapeutics?

Thc Therapeutics is trading at $0.00 per share.

What is the 52-week range for Thc Therapeutics?

Over the past 52 weeks, Thc Therapeutics has traded between $0.00 and $0.10.

How much debt does Thc Therapeutics have?

As of the most recent reporting period, Thc Therapeutics reported total debt of $876.90K.

How much cash does Thc Therapeutics have on hand?

Thc Therapeutics reported $35.00 in cash and cash equivalents in its most recent financial results.

What is Thc Therapeutics’s dividend yield?

Thc Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.